Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending REGN Q1 2026 Earnings EPS Beats Estimates by Nearly 4 Amidst Stable Performance RYN Q1 2026 Earnings Stellar EPS Surprise Defies Low Expectations AVBC Q1 2026 Earnings EPS Surpasses Estimates Amidst Potential Margin Pressures GNTX Q1 2026 Earnings EPS Beats Estimates by 38 Shares Edge Higher SUPV Q1 2026 Earnings Massive EPS Beat as Company Swings to Profitability